Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN

Author:

Döhner Hartmut1ORCID,Wei Andrew H.2ORCID,Appelbaum Frederick R.3,Craddock Charles4,DiNardo Courtney D.5ORCID,Dombret Hervé6,Ebert Benjamin L.7ORCID,Fenaux Pierre8,Godley Lucy A.9,Hasserjian Robert P.10ORCID,Larson Richard A.11ORCID,Levine Ross L.12,Miyazaki Yasushi13,Niederwieser Dietger14,Ossenkoppele Gert15,Röllig Christoph16,Sierra Jorge17ORCID,Stein Eytan M.18,Tallman Martin S.18,Tien Hwei-Fang19,Wang Jianxiang20ORCID,Wierzbowska Agnieszka21ORCID,Löwenberg Bob22ORCID

Affiliation:

1. 1Department of Internal Medicine III, Ulm University Hospital, Ulm, Germany;

2. 2Department of Haematology, Peter MacCallum Cancer Centre, Royal Melbourne Hospital and University of Melbourne, Melbourne, Australia;

3. 3University of Washington and the Fred Hutchinson Cancer Research Center, Seattle, WA;

4. 4Centre for Clinical Haematology, Queen Elizabeth Hospital, University of Birminham, Birmingham, UK;

5. 5Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX;

6. 6Department of Hematology, Saint-Louis Institute for Research, Université de Paris, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France;

7. 7Dana-Farber Cancer Institute, Boston, MA;

8. 8Service d’Hématologie Séniors, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France;

9. 9Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, IL;

10. 10Department of Pathology, Massachusetts General Hospital, Boston, MA;

11. 11Department of Medicine and Comprehensive Cancer Center, University of Chicago, Chicago, IL;

12. 12Human Oncology and Pathogenesis Program and Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY;

13. 13Department of Hematology, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan;

14. 14University of Leipzig, Leipzig, Germany;

15. 15Department of Haematology, Amsterdam UMC, Location VU University Medical Center, Amsterdam, The Netherlands;

16. 16Department of Internal Medicine I, University Hospital Carl Gustav Carus TU Dresden, Dresden, Germany;

17. 17Hematology Department, Hospital Santa Creu i Sant Pau, Barcelona, Spain;

18. 18Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York;

19. 19Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan;

20. 20Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China;

21. 21Department of Hematology, Medical University of Lodz, Lodz, Poland; and

22. 22Department of Hematology, Erasmus University Medical Center Rotterdam and Erasmus MC Cancer Institute, Rotterdam, The Netherlands

Abstract

AbstractThe 2010 and 2017 editions of the European LeukemiaNet (ELN) recommendations for diagnosis and management of acute myeloid leukemia (AML) in adults are widely recognized among physicians and investigators. There have been major advances in our understanding of AML, including new knowledge about the molecular pathogenesis of AML, leading to an update of the disease classification, technological progress in genomic diagnostics and assessment of measurable residual disease, and the successful development of new therapeutic agents, such as FLT3, IDH1, IDH2, and BCL2 inhibitors. These advances have prompted this update that includes a revised ELN genetic risk classification, revised response criteria, and treatment recommendations.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3